TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines
- PMID: 31158041
- PMCID: PMC6816368
- DOI: 10.1080/21645515.2019.1609823
TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines
Abstract
The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22-23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.
Keywords: TIPICO; infectious diseases; infectomics; vaccine hesitancy; vaccines; vaccinomics.
Similar articles
-
TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines.Hum Vaccin Immunother. 2021 Mar 4;17(3):759-772. doi: 10.1080/21645515.2020.1788301. Epub 2020 Aug 5. Hum Vaccin Immunother. 2021. PMID: 32755474 Free PMC article.
-
[The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].Ig Sanita Pubbl. 2017 Sep-Oct;73(5):405-418. Ig Sanita Pubbl. 2017. PMID: 29433128 Italian.
-
TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).Hum Vaccin Immunother. 2021 Nov 2;17(11):4299-4327. doi: 10.1080/21645515.2021.1953351. Epub 2021 Nov 11. Hum Vaccin Immunother. 2021. PMID: 34762551 Free PMC article.
-
Challenges in adult vaccination.Ann Med. 2018 May;50(3):181-192. doi: 10.1080/07853890.2017.1417632. Epub 2018 Jan 16. Ann Med. 2018. PMID: 29338438 Review.
-
Vaccine innovations for emerging infectious diseases-a symposium report.Ann N Y Acad Sci. 2020 Feb;1462(1):14-26. doi: 10.1111/nyas.14235. Epub 2019 Oct 28. Ann N Y Acad Sci. 2020. PMID: 31659752 Review.
References
-
- WHO WHO statement on cervical cancer elimination. 2018. December; https://www.who.int/reproductivehealth/DG_Call-to-Action.pdf.
-
- Bruni L, Serrano B, Diaz Sanchis M, Bosch FX, de Sanjosé Llongueras S.. Update of global estimates of HPV prevalence: meta-analysis of 2.4 million women with normal cytology. International Papillomavirus Conference (IPVC);
-
- Hall MT, Simms KT, Lew JB, Smith MA, Canfell K. The projected timeframe until cervical cancer elimination in Australia. (in preparation). - PubMed